Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 18Sanofi

02 2Regeneron Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Sweden

alirokumab

Brand Name : Praluent

Dosage Form : SOLUTION FOR INJECTION, PRE-FILLED SYRINGE

Dosage Strength : 150 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Sanofi Company Banner

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Sweden

alirokumab

Brand Name : Praluent

Dosage Form : SOLUTION FOR INJECTION, PRE-FILLED SYRINGE

Dosage Strength : 75 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Sanofi Company Banner

03

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Sweden

alirokumab

Brand Name : Praluent

Dosage Form : SOLUTION FOR INJECTION IN PRE-FILLED

Dosage Strength : 150 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Sanofi Company Banner

04

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Sweden

alirokumab

Brand Name : Praluent

Dosage Form : SOLUTION FOR INJECTION IN PRE-FILLED

Dosage Strength : 75 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Sanofi Company Banner

05

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 300 mg

Packaging : Pre-filled pen 3 2ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

06

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 75 mg/ml

Packaging : Pre-filled pen 2 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

07

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 75 mg/ml

Packaging : Pre-filled pen 6 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

08

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 75 mg/ml

Packaging : Pre-filled pen 1 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

09

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 150 mg/ml

Packaging : Pre-filled pen 6 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

10

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 150 mg/ml

Packaging : Pre-filled pen 1 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

11

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 150 mg/ml

Packaging : Pre-filled pen 2 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

12

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Switzerland

Alirocumab

Brand Name : Praluent

Dosage Form : Inj Sol

Dosage Strength : 150mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Sanofi Company Banner

13

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Switzerland

Alirocumab

Brand Name : Praluent

Dosage Form : Inj Sol

Dosage Strength : 75mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Sanofi Company Banner

14

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Switzerland

Alirocumab

Brand Name : Praluent

Dosage Form : Inj Sol

Dosage Strength : 75mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Sanofi Company Banner

15

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

ALIROCUMAB

Brand Name : PRALUENT

Dosage Form : SOLUTION

Dosage Strength : 75MG/ML

Packaging : 1ML

Approval Date :

Application Number : 2453819

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner

16

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

ALIROCUMAB

Brand Name : PRALUENT

Dosage Form : SOLUTION

Dosage Strength : 150MG/ML

Packaging : 1ML

Approval Date :

Application Number : 2453835

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner

17

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

ALIROCUMAB

Brand Name : PRALUENT 75 MG

Dosage Form : INJ

Dosage Strength : 75mg

Packaging : 1X2mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

18

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

ALIROCUMAB

Brand Name : PRALUENT 150 MG

Dosage Form : INJ

Dosage Strength : 150mg

Packaging : 1X2mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALIROCUMAB

Brand Name : PRALUENT

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 75MG

Packaging :

Approval Date :

Application Number : 125559

Regulatory Info :

Registration Country : USA

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALIROCUMAB

Brand Name : PRALUENT

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number : 125559

Regulatory Info :

Registration Country : USA

blank